XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Interim Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2025
Sep. 30, 2024
Current    
Cash and cash equivalents $ 101,164 $ 132,187
Incentive and tax receivables 820 2,449
Prepaid expenses and other current assets 448 931
Total Assets 102,432 135,567
Current Liabilities    
Accounts payable 6,740 9,627
Accrued liabilities - Note 3 3,929 4,835
Deferred grant income - Note 4 805 842
Total Liabilities 11,474 15,304
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share (0) (0)
Capital stock Authorized:200,000,000 common stock, par value $0.001 per share 84,985,449 common shares (September 30, 2024 - 84,795,517) 85 85
Additional paid-in capital 463,494 456,249
Accumulated deficit (372,621) (336,071)
Total Stockholders’ Equity 90,958 120,263
Total Liabilities and Stockholders’ Equity $ 102,432 $ 135,567